New website coming soon
Please bear with us while we migrate to our brand new website.
Biotechflow specialise in unique equipment for the isolation and purification of antibodies (e.g. MAb’s), therapeutic proteins and polypeptides direct from biomass (CHO cells; other mammalian cells; plasma; recombinant bacteria, yeasts, plants, milk, etc) – from laboratory to 100 - 5,000 litres biomass per run, cGMP Post-Phase III production scale. Potential for isolation of vaccine bodies/particles (with targetable epitopes) for vaccines, RNA, etc. This technology is currently particularly important for the large production scale isolation of antibodies and vaccines against COVID-19 (a Coronavirus).
Our Expanded Bed Chromatography Adsorption columns have been scaled-up from laboratory to cGMP full kg production commercial scale, Post-Phase III product in Europe, America and Australia over the last 10 years. Extremely comprehensive Validation Documentation including USP VI certs for all wetted parts, FAT, on-site IQ, OQ, installation and training included.
We have over 100 years combined experience in R&D, design and commercial production of chromatography columns – from 10-mm diameter to 2-metre diameter. Biotechflow equipment and methods have proven to reduce capital costs, process time, and clean room footprint to a third conventional methods (independent customer reference).